Answers are grounded in this paper and cite their sources.
This review outlines approaches for targeted therapy in adult ALL, highlighting treatment challenges and future directions.
This review provides a roadmap for the targeted therapy era in ALL, defining high-risk molecular subtypes and their targeted vulnerabilities. It synthesizes advances in BH3 mimetics, menin inhibition, and immunotherapy, while addressing the critical challenges of treatment resistance and phenotypic escape that define the next frontier of research.
No takes yet. Share an insight, caveat, or question.
Saygin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: